arrow
C

Carmen Busca

ciber de enfermedades infecciosas
H指数:21
被引数:2,780

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Bictegravir/emtricitabine/tenofovir alafenamide for primary HIV infection: efficacy, safety and impact on viral reservoir (the BIC-PHI clinical trial)

Bictegravir/emtricitabine/tenofovir alafenamide用于原发性HIV感染:疗效、安全性及对病毒库的影响(BIC-PHI临床研究)

2025-11-070
OAAI
Triglyceride–glucose index and FIB-4 score in relation to cardiovascular disease risk among people with HIV: a retrospective cohort study

甘油三酯–葡萄糖指数和FIB-4评分与HIV感染者心血管疾病风险的关系:一项回顾性队列研究

2025-11-060
OAAI
Comparable Inflammatory and Metabolic Outcomes After Switching to Bictegravir/Emtricitabine/Tenofovir Alafenamide Versus Continuing Dolutegravir/Lamivudine in Virologically Suppressed Adults With HIV (INSTINCT/GESIDA10918 Study)

与继续使用多替拉韦/拉米夫定相比,转换为比克替拉韦/恩曲他滨/替诺福韦艾拉酚胺后的炎症和代谢结局相当(INSTINCT/GESIDA10918研究)

2025-10-100
OA
Safety, immunogenicity and effect on viral rebound of HTI vaccines combined with a TLR7 agonist in early-treated HIV-1 infection: a randomized, placebo-controlled phase 2a trial

HTI疫苗联合TLR7激动剂在早期治疗HIV-1感染中的安全性、免疫原性及对病毒反弹的影响:一项随机、安慰剂对照的2a期试验

2025-03-040
OA
Clinical outcomes and prognostic factors after HCV clearance with DAA in HIV/HCV coinfected patients with advanced Fibrosis/Cirrhosis

HIV/HCV合并感染的晚期纤维化/肝硬化患者用DAA清除HCV后的临床结果和预后因素

2024-03-076
OAAI
Changes in Quality of Sleep, Mood, and Other Neuropsychiatric Symptoms After Switching Dolutegravir/Lamivudine/Abacavir to Darunavir/Cobicistat/Emtricitabine/Tenofovir Alafenamide in a Randomized Study of People With Human Immunodeficiency Virus With Poor Sleep Quality: GESIDA 10418
2022-08-068
OAAI
Impact of preexisting nucleos(t)ide reverse transcriptase inhibitor resistance on the effectiveness of bictegravir/emtricitabine/tenofovir alafenamide in treatment experience patients
AIDS
IF3.1
2022-07-0816
OAAI
Psoriasis and Liver Damage in HIV-Infected Patients
CELLS
IF5.2
2021-05-041
OAAI